{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:39:04Z","timestamp":1772627944529,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jbspin.2015.04.016","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T20:19:16Z","timestamp":1445631556000},"page":"81-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Rituximab as induction therapy in relapsing eosinophilic granulomatosis with polyangiitis: A report of 6 cases"],"prefix":"10.1016","volume":"83","author":[{"given":"Pavel","family":"Novikov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Moiseev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya","family":"Smitienko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Zagvozdkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2015.04.016_bib0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2013.03.003","article-title":"Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials","volume":"43","author":"Samson","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0015","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/ard.2005.047308","article-title":"Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndrome","volume":"65","author":"Kaushik","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00296-009-1146-6","article-title":"Churg-Strauss syndrome successfully treated with rituximab","volume":"31","author":"D\u00f8nvik","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0025","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/ard.2009.109850","article-title":"Successful use of rituximab in a patient with Churg-Strauss syndrome and refractory central nervous system involvement","volume":"69","author":"Saech","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000329535","article-title":"Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis","volume":"34","author":"Roccatello","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/ard.2005.042937","article-title":"Rituximab in Churg-Strauss syndrome","volume":"65","author":"Koukoulaki","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0040","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/rheumatology\/ken175","article-title":"Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production","volume":"47","author":"Pepper","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0045","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar4313","article-title":"Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)","volume":"15","author":"Thiel","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0050","article-title":"Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","author":"Mohammad","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0055","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American college of rheumatology 1990 criteria for the classification of Churg-Strauss-Syndrome (allergic granulomatosis and angiitis)","volume":"1990","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0075","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0080","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/art.21253","article-title":"Churg-Strauss syndrome: just one disease entity?","volume":"52","author":"Kallenberg","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/ard.2011.153601","article-title":"Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations","volume":"71","author":"Holle","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0090","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1136\/annrheumdis-2013-204809","article-title":"Five Factor Score in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss; EGPA): to use or not to use?","volume":"73","author":"Moiseev","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0095","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.autrev.2014.08.002","article-title":"Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors","volume":"13","author":"Samson","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2015.04.016_bib0100","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/ard.2008.093773","article-title":"Severe bronchospasm associated with rituximab for refractory Churg-Strauss syndrome","volume":"68","author":"Bouldouyre","year":"2009","journal-title":"Ann Rheum Dis"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15002183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15002183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T23:34:24Z","timestamp":1718148864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X15002183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1297319X15002183"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.04.016","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab as induction therapy in relapsing eosinophilic granulomatosis with polyangiitis: A report of 6 cases","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}